Deuchar Graeme A, Morecroft Ian, Dempsie Yvonne, Herold Nigel, Nilsen Margaret, Hicks Martin N, MacLean Margaret R
Division of Cardiovascular and Medical Science, Medical Cardiology, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, UK.
Eur J Pharmacol. 2006 May 10;537(1-3):135-42. doi: 10.1016/j.ejphar.2006.03.025. Epub 2006 Mar 17.
In vivo haemodynamic responses to human urotensin-II were determined in two models of pulmonary hypertension: rabbits with left ventricular dysfunction following coronary artery ligation and the hypoxic rat. Effects were also examined in the presence of the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME). Human urotensin-II increased pulmonary arterial pressure to a greater extent in ligated rabbits than their controls and L-NAME increased pulmonary pressure without significantly affecting these responses to human urotensin-II. Human urotensin-II raised right ventricular pressure slightly in control rats but not in hypoxic rats. Human urotensin-II did not constrict control rat isolated small pulmonary arteries and only induced a small constriction of these vessels in hypoxic rats. In conclusion, exogenous human urotensin-II exerts pulmonary pressor responses in vivo in rabbits and also induced small pulmonary pressor responses in control rats. Pulmonary pressor responses to urotensin-II were increased by pulmonary hypertension in rabbits but not in rats.